Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Retrospective Analysis of Prognostic Factors and Survival in Multiple Myeloma Patients Aged 65 Years or Older at Diagnosis in a Real-Life Setting and a Proposed New Staging System

Ali Tunc, Murad Guliyev, Tuba Özkan Tekin, Selin Kucukyurt, Umut Yilmaz, Eda Kantarci, Damla Ortaboz, Tuğrul Elverdi, Ahmet Emre Eşkazan, Şeniz Öngören, Muhlis Cem Ar, Zafer Başlar, Yildiz Aydin, Ayse Salihoglu

Blood (2022) 140 (Supplement 1): 12518–12519.

https://doi.org/10.1182/blood-2022-170159

Published: 2022

Journal Articles

Restless Legs Syndrome (RLS) in Patients (pts) with Polycythemia Vera (PV): Is Iron Deficiency (ID) the Only Culprit?

Duygu Seyhan Erdoğan, Gülçin Benbir Şenel, Ayşegül Gündüz, Beria Peren Uçar, Tuğrul Elverdi, Ayse Salihoglu, Muhlis Cem Ar, Şeniz Öngören, Zafer Başlar, Ahmet Emre Eşkazan

Blood (2022) 140 (Supplement 1): 12278–12279.

https://doi.org/10.1182/blood-2022-167347

Published: 2022

Journal Articles

The Impact of the COVID-19 Pandemic on the Diagnosis and Management of Patients with Classical Hodgkin Lymphoma: A Single-Center Experience

Selin Kucukyurt, Kübra Şahin, Umut Yılmaz, Abdülkadir Erçalışkan, Tuba Özkan Tekin, Damla Ortaboz, Tuğrul Elverdi, Ayşe Salihoğlu, Muhlis Cem Ar, Şeniz Öngören, Zafer Başlar, Ahmet Emre Eskazan

Blood (2021) 138 (Supplement 1): 1394.

https://doi.org/10.1182/blood-2021-152534

Published: 2021

Journal Articles

The Impact of EUTOS Long-Term Survival (ELTS) Score on Predicting Progression and Survival Among Turkish Patients with Chronic Myeloid Leukemia

Mert Bektaş, Tuğrul Elverdi, Ayşe Salihoğlu, Muhlis Cem Ar, Şeniz Öngören, Zafer Başlar, Teoman Soysal, Ahmet Emre Eşkazan

Blood (2021) 138 (Supplement 1): 4600.

https://doi.org/10.1182/blood-2021-149198

Published: 2021

Journal Articles

Treatment Responses, Toxicity and Survival in Patients with Classical Hodgkin Lymphoma Aged 50 Years and Older: A Single-Center Experience over 2 Decades

Simay Çokgezer, Tuğrul Elverdi, Ayşe Salihoğlu, Muhlis Cem Ar, Şeniz Öngören, Zafer Başlar, Ahmet Emre Eşkazan

Blood (2021) 138 (Supplement 1): 4541.

https://doi.org/10.1182/blood-2021-149179

Published: 2021

Journal Articles

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Veysel Suzan, MD, Nurgul Ozgur Yurttas, MD, Ahmet Emre Eskazan, MD, Deniz Ozmen, MD, Dilek Keskin, MD, Sevil Sadri, MD, Selin Berk, MD, Isil Erdogan, MD, Tugrul Elverdi, MD, Ayse Salihoglu, MD, Muhlis Cem Ar, MD PhD, Zafer Baslar, MD

Blood (2019) 134 (Supplement_1): 4933.

https://doi.org/10.1182/blood-2019-130305

Published: 2019

Journal Articles

Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience

Deniz Ozmen, Dilek Keskin, MD, Nurgul Ozgur Yurttas, MD, Sevil Sadri, MD, Ayse Salihoglu, MD, Ahmet Emre Eskazan, MD, M. Cem Ar, MD PhD, Seniz Ongoren, MD, Zafer Baslar, MD, Teoman Soysal, MD

Blood (2017) 130 (Supplement 1): 5349.

https://doi.org/10.1182/blood.V130.Suppl_1.5349.5349

Published: 2017

Journal Articles

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

Nurgul Ozgur Yurttas, MD, Burak Sarilar, MD, Ahmet Emre Eskazan, MD, Deniz Ozmen, MD, Dilek Keskin, MD, Sevil Sadri, MD, Selin Berk, MD, Ayse Salihoglu, MD, M. Cem Ar, MD PhD, Seniz Ongoren, MD, Zafer Baslar, MD, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2017) 130 (Supplement 1): 2888.

https://doi.org/10.1182/blood.V130.Suppl_1.2888.2888

Published: 2017

Journal Articles

Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia

Ahmet Emre Eskazan, MD, Mert Oztas, MD, Fatih Bektas, MD, Sevil Sadri, MD, Dilek Keskin, MD, Nurgul Ozgur Yurttas, MD, Selin Berk, MD, Isil Erdogan Ozunal, MD, Ayse Salihoglu, MD, M. Cem Ar, MD PhD, Seniz Ongoren, MD, Zafer Baslar, MD, Ugur Ozbek, MD PhD, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2016) 128 (22): 1905.

https://doi.org/10.1182/blood.V128.22.1905.1905

Published: 2016

Journal Articles

Haemophilic Arthropathy Is a Risk Factor for Reduced Bone Mineral Density and Vitamin D Deficiency

M. Cem Ar, MD PhD, Serdar Sahin, MD, Sevil Sadri, MD, Isil Erdogan, MD, Ayse Salihoglu, MD, Tugrul Elverdi, MD, Fevzi Firat Yalniz, MD, Ahmet Emre Eskazan, MD, Seniz Ongoren, MD Associated Proffessor, Teoman Soysal, MD, Yildiz Aydin, MD, Zafer Baslar, MD

Blood (2015) 126 (23): 4685.

https://doi.org/10.1182/blood.V126.23.4685.4685

Published: 2015

Journal Articles

New CNV Regions Identified in ITP Provide Evidence for Genetic Predisposition

M. Cem Ar, MD PhD, Emrah Yucesan, PhD, Firat Yalniz, MD, Ozden Hatirnaz Ng, PhD, Ayse Salihoglu, MD, Selin Berk, MD, Ahmet Emre Eskazan, MD, Seniz Ongoren, MD Associated Proffessor, Zafer Baslar, MD, Ugur Ozbek, MD PhD, Teoman Soysal, MD, Yildiz Aydin, MD, Muge Sayitoglu, PhD

Blood (2015) 126 (23): 77.

https://doi.org/10.1182/blood.V126.23.77.77

Published: 2015

Journal Articles

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias

Nurgul Ozgur Yurttas, MD, Sevil Sadri, MD, Dilek Keskin, MD, Selin Berk, MD, Isil Erdogan Oztunali, MD, Fevzi Firat Yalniz, MD, Ayse Salihoglu, MD, Ahmet Emre Eskazan, MD, M. Cem Ar, MD PhD, Seniz Ongoren Aydin, MD, Zafer Baslar, MD, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2015) 126 (23): 4037.

https://doi.org/10.1182/blood.V126.23.4037.4037

Published: 2015

Journal Articles

Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

Eda Tanrikulu Simsek, MD, Ahmet Emre Eskazan, MD, Mahir Cengiz, MD, M. Cem Ar, MD PhD, Seda Ekizoglu, PhD, Ayse Salihoglu, MD, Emine Gulturk, MD, Tugrul Elverdi, MD, Seniz Ongoren Aydin, MD, Ahu Senem Demiroz, MD, Ayse Nur Buyru, MD, Zafer Baslar, MD, Ugur Ozbek, MD PhD, A. Burhan Ferhanoglu, MD, Yildiz Aydin, MD, Nukhet Tuzuner, MD Professor, Teoman Soysal, MD

Blood (2015) 126 (23): 2783.

https://doi.org/10.1182/blood.V126.23.2783.2783

Published: 2015

Journal Articles

Posttransplant Secondary Neoplasms: A Single Center Experience

Selin Berk, MD, Dilek Keskin, MD, Nurgul Ozgur Yurttas, MD, Sevil Sadri, MD, Isil Erdogan, MD, Firat Yalniz, MD, Tugrul Elverdi, MD, Ayse Salihoglu, MD, Ahmet Emre Eskazan, MD, M. Cem Ar, MD PhD, Seniz Ongoren, MD Associated Proffessor, Zafer Baslar, MD, Nukhet Tuzuner, MD Professor, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2015) 126 (23): 5485.

https://doi.org/10.1182/blood.V126.23.5485.5485

Published: 2015

Journal Articles

The Prognostic Value of Serum APRIL Levels in Patients with Chronic Lymphocytic Leukemia

Sinem Nihal Esatoglu, MD, Dilek Keskin, MD, Muge Kutnu, MD, Tugrul Elverdi, Fellow, Ayse Salihoglu, Hematologist, Ahmet Emre Eskazan, Hematologist, Muhlis Cem AR, Associate Professor, Seniz Ongoren Aydin, Associate Professor, Zafer Baslar, Professor Doctor, Yildiz Aydin, Professor Doctor, Hanife Uzun, Professor Doctor, Teoman Soysal, Professor Doctor

Blood (2014) 124 (21): 5648.

https://doi.org/10.1182/blood.V124.21.5648.5648

Published: 2014

Journal Articles

Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update

Guray Saydam, MD Prof, Ibrahim Celalettin Haznedaroglu, MD, Leylagul Kaynar, MD, Akif S. Yavuz, MD Prof, Ridvan Ali, Prof MD, Birol Guvenc, MD Prof, Olga M. Akay, MD, Zafer Baslar, Professor Doctor, Ugur Ozbek, MD PhD, Mehmet Sonmez, MD, Demet Aydin, MD, Mustafa Pehlivan, MD Assoc Prof, Bulent Undar, MD Prof, Simten Dagdas, MD Assoc Prof, Orhan M. Ayyildiz, MD Prof, Diyar Z. Akkaynak, MD, Ilkiz M. Dag, MD, Osman Ilhan, MD

Blood (2014) 124 (21): 5532.

https://doi.org/10.1182/blood.V124.21.5532.5532

Published: 2014

Journal Articles

Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia

Guray Saydam, MD, Prof, Ibrahim C. Haznedaroglu, MD, Prof, Leylagul Kaynar, MD, Prof, Akif S. Yavuz, MD, Prof, Ridvan Ali, MD, Prof, Birol Guvenc, MD, Prof, Olga M. Akay, MD, Zafer Baslar, Professor Doctor, Ugur Ozbek, MD, Prof, Mehmet Sonmez, M.D., Demet Aydin, MD, Mustafa Pehlivan, MD, Assoc Prof, Bulent Undar, MD, Prof, Simten Dagdas, MD, Assoc Prof, Orhan M. Ayyildiz, MD, Prof, Diyar Z. Akkaynak, MD, Ilkiz M. Dag, MD, Osman Ilhan, MD, Prof

Blood (2013) 122 (21): 2742.

https://doi.org/10.1182/blood.V122.21.2742.2742

Published: 2013

Journal Articles

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Yucel Erbilgin, Ahmet Emre Eskazan, Ozden Hatirnaz Ng, PhD, Ayse Salihoglu, Tugrul Elverdi, MD, Sinem Firtina, Suzin Catal Tatonyan, Seniz Ongoren Aydin, Muhlis Cem Ar, Zafer Baslar, Muge Sayitoglu, PhD, A. Burhan Ferhanoglu, Yildiz Aydin, Ugur Ozbek, Teoman Soysal

Blood (2013) 122 (21): 384.

https://doi.org/10.1182/blood.V122.21.384.384

Published: 2013

Journal Articles

Functional Characterization of the Type 1 VWD Candidate VWF Gene Variants: P.M771I, p.L881R, p.P1413L, and p.Q1475X

Ergul Berber, PhD, Christine Brown, Kutluhan Incekara, Zafer Baslar, Hande Caglayan, David Lillicrap, MD

Blood (2012) 120 (21): 97.

https://doi.org/10.1182/blood.V120.21.97.97

Published: 2012

Journal Articles

Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience

Suzan Alp, Ayse Salihoglu, Ahmet Emre Eskazan, Emine Gulturk, M. Cem Ar, Seniz Ongoren Aydin, Zafer Baslar, Ayse Nur Buyru, Ugur Ozbek, A. Burhan Ferhanoglu, Yildiz Aydin, Teoman Soysal

Blood (2011) 118 (21): 4429.

https://doi.org/10.1182/blood.V118.21.4429.4429

Published: 2011

NARROW

Retrospective Analysis of Prognostic Factors and Survival in Multiple Myeloma Patients Aged 65 Years or Older at Diagnosis in a Real-Life Setting and a Proposed New Staging System

Restless Legs Syndrome (RLS) in Patients (pts) with Polycythemia Vera (PV): Is Iron Deficiency (ID) the Only Culprit?

The Impact of the COVID-19 Pandemic on the Diagnosis and Management of Patients with Classical Hodgkin Lymphoma: A Single-Center Experience

The Impact of EUTOS Long-Term Survival (ELTS) Score on Predicting Progression and Survival Among Turkish Patients with Chronic Myeloid Leukemia

Treatment Responses, Toxicity and Survival in Patients with Classical Hodgkin Lymphoma Aged 50 Years and Older: A Single-Center Experience over 2 Decades

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia

Haemophilic Arthropathy Is a Risk Factor for Reduced Bone Mineral Density and Vitamin D Deficiency

New CNV Regions Identified in ITP Provide Evidence for Genetic Predisposition

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias

Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

Posttransplant Secondary Neoplasms: A Single Center Experience

The Prognostic Value of Serum APRIL Levels in Patients with Chronic Lymphocytic Leukemia

Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update

Use Of Nilotinib As a First Line Treatment In Adult Patients With Philadelphia Chromosome-Positive and Chronic Phase Myeloid Leukemia

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Functional Characterization of the Type 1 VWD Candidate VWF Gene Variants: P.M771I, p.L881R, p.P1413L, and p.Q1475X

Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only